RGNX - Regenxbio GAAP EPS of -$1.41 beats by $0.07 revenue of $28.91M beats by $3.12M
2023-11-08 16:14:44 ET
More on Regenxbio
- Regenxbio: Biotech To Watch With 2 Possible Accelerated Approval Pathways
- Regenxbio: Promising Yet Risky Therapeutic Horizon
- Regenxbio Q3 2023 Earnings Preview
- Stifel starts Regenxbio at buy; cites broad platform, deep portfolio
- Seeking Alpha’s Quant Rating on Regenxbio
For further details see:
Regenxbio GAAP EPS of -$1.41 beats by $0.07, revenue of $28.91M beats by $3.12M